Alumis, Inc. (ALMS)
23.29
+0.26
(+1.13%)
USD |
NASDAQ |
Aug 25, 13:07
Alumis Debt to Equity Ratio : 0.0806 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0806 |
| March 31, 2026 | 0.0629 |
| December 31, 2025 | 0.1225 |
| September 30, 2025 | 0.0982 |
| June 30, 2025 | 0.0799 |
| March 31, 2025 | 0.1894 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.1181 |
| September 30, 2024 | 0.0893 |
| June 30, 2024 | 0.1575 |
| March 31, 2024 | 0.2925 |
| December 31, 2023 | 0.9022 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Corcept Therapeutics, Inc. | 0.0133 |
| Aclaris Therapeutics, Inc. | 0.0149 |
| Crinetics Pharmaceuticals, Inc. | 0.0396 |
| Tarsus Pharmaceuticals, Inc. | 0.2557 |
| Structure Therapeutics, Inc. | 0.0046 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 560.62M |
| Total Liabilities (Quarterly) | 108.46M |
| Shareholders Equity (Quarterly) | 452.16M |
| Current Ratio | 6.744 |
| Net Debt Paydown Yield | -0.03% |